Stroke Association/BHF Joint Programme Grant
Disease of the chest portion of the largest artery in the body (the aorta), is known as thoracic aortic disease (TAD). The number of people experiencing TAD is increasing. This study is investigating how to make thoracic endovascular aortic stenting (TEVAR), the preferred method of treating TAD, safer by using extra protection devices.
How should we best prevent narrowed neck arteries causing stroke?
We are a proud partner in the National Prevention Research Initiative (NPRI), a partnership of 16 health research funders including government departments, research councils and medical charities. Launched today, a new report sheds light on the NPRI's fresh approach to preventing ill health.
Does intensive blood pressure and cholesterol lowering prevent loss of cognition after stroke?
This study will show whether more intensive lowering of blood pressure (BP) in survivors of intracerebral haemorrhage (ICH) is feasible, safe and effective in reducing brain injury. If successful, the study will pave the way for the design a larger definitive trial.
Professor Joanna Wardlaw CBE talks about the new SVDs@target programme - Targeting interventions for small vessel disease to prevent stroke and dementia. This programme was funded by a 6 million euro grant from the European Union’s Horizon 2020 programme.
PRESTIGE-AF is a new multi-million Euro initiative funded by the European Commission has been set up to help prevent stroke in patients with existing conditions.
Stroke Association/BHF Joint Programme Grant: Can a drug commonly used for gout improve recovery and prevention of further stroke for stroke survivors?
Published in the journal, PLOS ONE, a new study sheds light on how feasible it is to conduct a large trial of intensive blood pressure lowering, and cholesterol lowering treatment after stroke, to see if these prevent patients developing memory and thinking problems (cognitve impairment). In some cases, cognitive impairment can progress and lead to dementia after stroke.